Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation

por Pasin, Chloé, Moy, Ryan H., Reshef, Ran, Yates, Andrew J.
Publicado 2021

Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy

por Vercellino, Laetitia, de Jong, Dorine, di Blasi, Roberta, Kanoun, Salim, Reshef, Ran, Schwartz, Lawrence H., Dercle, Laurent
Publicado 2021

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

por Nagle, Sarah J, Shah, Nirav N, Ganetsky, Alex, Landsburg, Daniel J, Nasta, Sunita D, Mato, Anthony, Schuster, Stephen J, Reshef, Ran, Tsai, Donald E, Svoboda, Jakub
Publicado 2017

Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD

por Oren, Daniel, DeFilippis, Ersilia M., Lotan, Dor, Clerkin, Kevin J., Fried, Justin, Reshef, Ran, Fernandez, Hilda, Lin, Edward, Amengual, Jennifer, Sayer, Gabriel, Uriel, Nir, Raikhelkar, Jayant K.
Publicado 2022

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and...

por Putta, Santosh, Young, Bradford A., Levine, John E., Reshef, Ran, Nakamura, Ryotaro, Strouse, Christopher, Perales, Miguel-Angel, Howard, Alan, Pine, Polly, Shi, Ju, Zhang, Peixin, Ho, Vincent T., Saber, Wael
Publicado 2023

Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease

por Rager, Alison, Frey, Noelle, Goldstein, Steven C, Reshef, Ran, Hexner, Elizabeth O, Loren, Alison, Luger, Selina M, Perl, Alexander, Tsai, Donald, Davis, Jennifer, Vozniak, Michael, Smith, Jacqueline, Stadtmauer, Edward A, Porter, David L
Publicado 2010

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

por Lefebvre, Eric, Moyle, Graeme, Reshef, Ran, Richman, Lee P., Thompson, Melanie, Hong, Feng, Chou, Hsin-l, Hashiguchi, Taishi, Plato, Craig, Poulin, Dominic, Richards, Toni, Yoneyama, Hiroyuki, Jenkins, Helen, Wolfgang, Grushenka, Friedman, Scott L.
Publicado 2016

Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity

por He, Shan, Liu, Yongnian, Meng, Lijun, Sun, Hongxing, Wang, Ying, Ji, Yun, Purushe, Janaki, Chen, Pan, Li, Changhong, Madzo, Jozef, Issa, Jean-Pierre, Soboloff, Jonathan, Reshef, Ran, Moore, Bethany, Gattinoni, Luca, Zhang, Yi
Publicado 2017

Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11

por Jain, Michael D., Miklos, David B., Jacobson, Caron A., Timmerman, John M., Sun, Jennifer, Nater, Jenny, Fang, Xiang, Patel, Ankit, Davis, Madison, Heeke, Darren, Trinh, Tan, Mattie, Mike, Neumann, Frank, Kim, Jenny J., To, Christina, Filosto, Simone, Reshef, Ran
Publicado 2023

P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

por Flinn, Ian W., Jacobson, Caron, Nastoupil, Loretta J., Morschhauser, Franck, Davies, Andrew J., Buske, Christian, Corradini, Paolo, Lopez-Guillermo, Armando, Reshef, Ran, Parameswaran, Vinod, Sehgal, Alison, Tees, Michael, Lui, Christine, Xue, Wei, Beygi, Sara, Grechko, Nikolay, Bolsue, Pisita, Giovanetti, Alessandro, To, Christina, Nahas, Myrna
Publicado 2023

TGM4: an immunogenic prostate-restricted antigen

por Lopez-Bujanda, Zoila A, Obradovic, Aleksandar, Nirschl, Thomas R, Crowley, Laura, Macedo, Rodney, Papachristodoulou, Alexandros, O’Donnell, Timothy, Laserson, Uri, Zarif, Jelani C, Reshef, Ran, Yuan, Tiezheng, Soni, Mithil K, Antonarakis, Emmanuel S, Haffner, Michael C, Larman, H Benjamin, Shen, Michael M, Muranski, Pawel, Drake, Charles G
Publicado 2021

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

por Mayor, Neema P., Wang, Tao, Lee, Stephanie J., Kuxhausen, Michelle, Vierra-Green, Cynthia, Barker, Dominic J., Auletta, Jeffrey, Bhatt, Vijaya R., Gadalla, Shahinaz M., Gragert, Loren, Inamoto, Yoshihiro, Morris, Gerald P., Paczesny, Sophie, Reshef, Ran, Ringdén, Olle, Shaw, Bronwen E., Shaw, Peter, Spellman, Stephen R., Marsh, Steven G. E.
Publicado 2021

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treate...

por Nikiforow, Sarah, Wang, Tao, Hemmer, Michael, Spellman, Stephen, Akpek, Görgün, Antin, Joseph H., Choi, Sung Won, Inamoto, Yoshihiro, Khoury, Hanna J., MacMillan, Margaret, Marks, David I., Meehan, Ken, Nakasone, Hideki, Nishihori, Taiga, Olsson, Richard, Paczesny, Sophie, Przepiorka, Donna, Reddy, Vijay, Reshef, Ran, Schoemans, Hélène, Waller, Ned, Weisdorf, Daniel, Wirk, Baldeep, Horowitz, Mary, Alousi, Amin, Couriel, Daniel, Pidala, Joseph, Arora, Mukta, Cutler, Corey
Publicado 2018

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

por Goyal, Sagun D., Zhang, Mei-Jie, Wang, Hai-Lin, Akpek, Görgün, Copelan, Edward A., Freytes, César, Gale, Robert Peter, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Ritchie, David S., Saber, Wael, Savani, Bipin N., Seber, Adriana, Shea, Thomas C., Tallman, Martin S., Wirk, Baldeep, Bunjes, Donald W., Devine, Steven M., de Lima, Marcos, Weisdorf, Daniel J., Uy, Geoffrey L.
Publicado 2015

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

por Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara A., Patel, Dhwani, Smith, Eric L., Korde, Neha, Lu, Sydney X., Mailankody, Sham, Shah, Urvi A., Lesokhin, Alexander M., Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkach, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetzky, David, Braunstein, Marc J., Gordillo, Christian, Reshef, Ran, Taur, Ying, Davies, Faith E., Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth J., Landgren, Ola
Publicado 2020

What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak

por Mehta, Monica, Purpura, Lawrence J., McConville, Thomas H., Neidell, Matthew J., Anderson, Michaela R., Bernstein, Elana J., Dietz, Donald E., Laracy, Justin, Gunaratne, Shauna H., Miller, Emily Happy, Cheng, Jennifer, Zucker, Jason, Shah, Shivang S., Chaudhuri, Shaoli, Gordillo, Christian A., Patel, Shreena R., Guo, Tai Wei, Karaaslan, Lara E., Reshef, Ran, Miko, Benjamin A., Bathon, Joan M., Pereira, Marcus R., Uhlemann, Anne-Catrin, Yin, Michael T., Sobieszczyk, Magdalena E.
Publicado 2021

The utility of biomarkers in acute GVHD prognostication

por Spyrou, Nikolaos, Akahoshi, Yu, Ayuk, Francis, Holler, Ernst, Choe, Hannah, Etra, Aaron, Hogan, William J., Rösler, Wolf, Hexner, Elizabeth, DeFilipp, Zachariah, Reshef, Ran, Chanswangphuwana, Chantiya, Qayed, Muna, Kraus, Sabrina, Eder, Matthias, Javorniczky, Nora Rebeka, Grupp, Stephan A., Kitko, Carrie L., Merli, Pietro, Aguayo-Hiraldo, Paibel, Wölfl, Matthias, Baez, Janna, Beheshti, Rahnuma, Eng, Gilbert, Gleich, Sigrun, Katsivelos, Nikolaos, Khan, Alina, Kowalyk, Steven, Morales, George, Young, Rachel, Nakamura, Ryotaro, Chen, Yi-Bin, Levine, John E., Ferrara, James L. M.
Publicado 2023

Disease Risk and GVHD Biomarkers Can Stratify Patients For Risk of Relapse and Non-Relapse Mortality Post Hematopoietic Cell Transplant

por Aziz, Mina D., Shah, Jay, Kapoor, Urvi, Dimopoulos, Christina, Anand, Sarah, Augustine, Allan, Ayuk, Francis, Chaudhry, Mohammed, Chen, Yi-Bin, Choe, Hannah K., Etra, Aaron, Gergoudis, Stephanie, Hartwell, Matthew J., Hexner, Elizabeth O., Hogan, William J., Kitko, Carrie L., Kowalyk, Steven, Kröger, Nicolaus, Merli, Pietro, Morales, George, Nakamura, Ryotaro, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Schreiner, Elisabeth, Srinagesh, Hrishikesh, Wölfl, Matthias, Wudhikarn, Kitsada, Yanik, Gregory, Young, Rachel, Özbek, Umut, Ferrara, James L.M., Levine, John E.
Publicado 2020

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

por Etra, Aaron, Gergoudis, Stephanie, Morales, George, Spyrou, Nikolaos, Shah, Jay, Kowalyk, Steven, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Chen, Yi-Bin, Choe, Hannah, DeFilipp, Zachariah, Gandhi, Isha, Hexner, Elizabeth, Hogan, William J., Holler, Ernst, Kapoor, Urvi, Kitko, Carrie L., Kraus, Sabrina, Lin, Jung-Yi, Al Malki, Monzr, Merli, Pietro, Pawarode, Attaphol, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Van Hyfte, Grace, Weber, Daniela, Wölfl, Matthias, Young, Rachel, Özbek, Umut, Ferrara, James L. M., Levine, John E.
Publicado 2022

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

por Akahoshi, Yu, Spyrou, Nikolaos, Hogan, William J., Ayuk, Francis, DeFilipp, Zachariah, Weber, Daniela, Choe, Hannah K., Hexner, Elizabeth O., Rösler, Wolf, Etra, Aaron M., Sandhu, Karamjeet, Yanik, Gregory A., Chanswangphuwana, Chantiya, Kitko, Carrie L., Reshef, Ran, Kraus, Sabrina, Wölfl, Matthias, Eder, Matthias, Bertrand, Hannah, Qayed, Muna, Merli, Pietro, Grupp, Stephan A., Aguayo-Hiraldo, Paibel, Schechter, Tal, Ullrich, Evelyn, Baez, Janna, Beheshti, Rahnuma, Gleich, Sigrun, Kowalyk, Steven, Morales, George, Young, Rachel, Kwon, Deukwoo, Nakamura, Ryotaro, Levine, John E., Ferrara, James L. M., Chen, Yi-Bin
Publicado 2023